New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

Drug Metabolism and Disposition Volume 31 Issue 7

2013
- Volume 41
  - Issue 2 (Feb)
  - Issue 1 (Jan)
2012
- Volume 40
2011
- Volume 39
2010
- Volume 38
2009
- Volume 37
2008
- Volume 36
2007
- Volume 35
2006
- Volume 34
2005
- Volume 33
2004
- Volume 32
2003
- Volume 31
2002
- Volume 30
2001
- Volume 29
2000
- Volume 28
1999
- Volume 27
1998
- Volume 26
1997
- Volume 25

Bookmark
More Like This oai7wsufJh Preview Only

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Bjornsson, Thorir D.; Callaghan, John T.; Einolf, Heidi J.; Fischer, Volker; Gan, Lawrence; Grimm, Scott; Kao, John; King, S. Peter; Miwa, Gerald; Ni, Lan; Kumar, Gondi; McLeod, James; Obach, R. Scott; Roberts, Stanley; Roe, Amy; Shah, Anita; Snikeris, Fred; Sullivan, John T.; Tweedie, Donald; Vega, Jose M.; Walsh, John; Wrighton, Steven A.

Follow Drug Metabolism and Disposition , Volume 31 (7): 815 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This Dbnh7vkoKS Preview Only

KINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEIN

Hagrman, Douglas; Goodisman, Jerry; Dabrowiak, James C.; Souid, Abdul-Kader

Follow Drug Metabolism and Disposition , Volume 31 (7): 916 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This 0Stuvi0l8r Preview Only

CYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANS

Tippin, Timothy K.; Hamilton, Geraldine; Moore, Linda; Beaudet, Elizabeth J.; Jolley, Summer; Brodie, Thomas A.; Andrews, Robert C.; Becherer, J. David; McDougald, Darryl L.; Gaul, Michael D.; Hoivik, Debie J.; Mellon-Kusibab, Kathy; Lehmann, Jurgen; Kliewer, Steven; Novick, Steven; Laethem, Ron; Zhao, Zhiyang; LeCluyse, Edward L.

Follow Drug Metabolism and Disposition , Volume 31 (7): 870 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This LoH064v77l Preview Only

METABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKE

Demady, Damon R.; Lowe, Ezra R.; Everett, Andrew C.; Billecke, Scott S.; Kamada, Yasuhiko; Dunbar, Anwar Y.; Osawa, Yoichi

Follow Drug Metabolism and Disposition , Volume 31 (7): 932 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This spAWWsT0IA Preview Only

IN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREA

Watanabe, Takaho; Morisseau, Christophe; Newman, John W.; Hammock, Bruce D.

Follow Drug Metabolism and Disposition , Volume 31 (7): 846 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This Gfv9a5JxL9 Preview Only

IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES

Wynalda, Michael A.; Hutzler, J. Matthew; Koets, Michael D.; Podoll, Terry; Wienkers, Larry C.

Follow Drug Metabolism and Disposition , Volume 31 (7): 878 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This nBJ2xY4TOf Preview Only

TWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIES

Lattard, Virginie; Zhang, Jun; Tran, Quyen; Furnes, Bjarte; Schlenk, Daniel; Cashman, John R.

Follow Drug Metabolism and Disposition , Volume 31 (7): 854 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This M0zkjrr0HA Preview Only

DECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Mörck, Anna; Hakk, Heldur; Örn, Ulrika; Wehler, Eva Klasson

Follow Drug Metabolism and Disposition , Volume 31 (7): 900 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This 3GZOuzwYTM Preview Only

PROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATS

Zhang, Donglu; Ogan, Marc; Gedamke, Richard; Roongta, Vikram; Dai, Renke; Zhu, Mingshe; Rinehart, J. Kent; Klunk, Lewis; Mitroka, James

Follow Drug Metabolism and Disposition , Volume 31 (7): 837 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003
Bookmark
More Like This VPOqSRqSjW Preview Only

CYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATION

Weaver, Richard; Graham, Ken S.; Beattie, Iain G.; Riley, Rob J.

Follow Drug Metabolism and Disposition , Volume 31 (7): 955 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Drug Metabolism and Disposition Volume 31 Issue 7

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Follow Drug Metabolism and Disposition , Volume 31 (7): 815 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

KINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEIN

Hagrman, Douglas; Goodisman, Jerry; Dabrowiak, James C.; Souid, Abdul-Kader

Follow Drug Metabolism and Disposition , Volume 31 (7): 916 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

CYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANS

Follow Drug Metabolism and Disposition , Volume 31 (7): 870 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

METABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKE

Demady, Damon R.; Lowe, Ezra R.; Everett, Andrew C.; Billecke, Scott S.; Kamada, Yasuhiko; Dunbar, Anwar Y.; Osawa, Yoichi

Follow Drug Metabolism and Disposition , Volume 31 (7): 932 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

IN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREA

Watanabe, Takaho; Morisseau, Christophe; Newman, John W.; Hammock, Bruce D.

Follow Drug Metabolism and Disposition , Volume 31 (7): 846 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES

Wynalda, Michael A.; Hutzler, J. Matthew; Koets, Michael D.; Podoll, Terry; Wienkers, Larry C.

Follow Drug Metabolism and Disposition , Volume 31 (7): 878 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

TWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIES

Lattard, Virginie; Zhang, Jun; Tran, Quyen; Furnes, Bjarte; Schlenk, Daniel; Cashman, John R.

Follow Drug Metabolism and Disposition , Volume 31 (7): 854 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

DECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Mörck, Anna; Hakk, Heldur; Örn, Ulrika; Wehler, Eva Klasson

Follow Drug Metabolism and Disposition , Volume 31 (7): 900 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

PROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATS

Zhang, Donglu; Ogan, Marc; Gedamke, Richard; Roongta, Vikram; Dai, Renke; Zhu, Mingshe; Rinehart, J. Kent; Klunk, Lewis; Mitroka, James

Follow Drug Metabolism and Disposition , Volume 31 (7): 837 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

CYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATION

Weaver, Richard; Graham, Ken S.; Beattie, Iain G.; Riley, Rob J.

Follow Drug Metabolism and Disposition , Volume 31 (7): 955 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Advanced Filters:

Specific Data Sources:

Drug Metabolism and Disposition Volume 31 Issue 7

1 - 10 of 19 articles

Follow Drug Metabolism and Disposition , Volume 31 (7): 815 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Hagrman, Douglas; Goodisman, Jerry; Dabrowiak, James C.; Souid, Abdul-Kader

Follow Drug Metabolism and Disposition , Volume 31 (7): 916 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Follow Drug Metabolism and Disposition , Volume 31 (7): 870 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Demady, Damon R.; Lowe, Ezra R.; Everett, Andrew C.; Billecke, Scott S.; Kamada, Yasuhiko; Dunbar, Anwar Y.; Osawa, Yoichi

Follow Drug Metabolism and Disposition , Volume 31 (7): 932 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Watanabe, Takaho; Morisseau, Christophe; Newman, John W.; Hammock, Bruce D.

Follow Drug Metabolism and Disposition , Volume 31 (7): 846 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Wynalda, Michael A.; Hutzler, J. Matthew; Koets, Michael D.; Podoll, Terry; Wienkers, Larry C.

Follow Drug Metabolism and Disposition , Volume 31 (7): 878 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Lattard, Virginie; Zhang, Jun; Tran, Quyen; Furnes, Bjarte; Schlenk, Daniel; Cashman, John R.

Follow Drug Metabolism and Disposition , Volume 31 (7): 854 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Mörck, Anna; Hakk, Heldur; Örn, Ulrika; Wehler, Eva Klasson

Follow Drug Metabolism and Disposition , Volume 31 (7): 900 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Zhang, Donglu; Ogan, Marc; Gedamke, Richard; Roongta, Vikram; Dai, Renke; Zhu, Mingshe; Rinehart, J. Kent; Klunk, Lewis; Mitroka, James

Follow Drug Metabolism and Disposition , Volume 31 (7): 837 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003

Weaver, Richard; Graham, Ken S.; Beattie, Iain G.; Riley, Rob J.

Follow Drug Metabolism and Disposition , Volume 31 (7): 955 Am. Soc for Pharma & Experimental Therapeutics – Jul 1, 2003